Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications

dc.contributor.authorAkinci, Sinan
dc.contributor.authorConer, Ali
dc.contributor.authorAkbay, Ertan
dc.contributor.authorAdar, Adem
dc.contributor.authorMuderrisoglu, Haldun
dc.contributor.pubmedID36200724en_US
dc.date.accessioned2022-10-31T15:12:48Z
dc.date.available2022-10-31T15:12:48Z
dc.date.issued2022
dc.identifier.endpage546en_US
dc.identifier.issn1016-5169en_US
dc.identifier.issue7en_US
dc.identifier.scopus2-s2.0-85139283801en_US
dc.identifier.startpage545en_US
dc.identifier.urihttp://hdl.handle.net/11727/7930
dc.identifier.volume50en_US
dc.identifier.wos000865992400015en_US
dc.language.isoengen_US
dc.relation.isversionof10.5543/tkda.2022.220922en_US
dc.relation.journalTURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAnswer Regarding: Potent P2Y12 Inhibitors and Bleeding Complicationsen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: